Algorithmic Trading Model As At 21 December 2021: Novavax, BioNTech & Moderna
Long/Short Equity, Medium-Term Horizon, Deep Value
Seeking Alpha Analyst Since 2009
My retail trader book series, The Paranoid Trader and The BIG FISH Trader, is now available on Amazon.
It is a strategy guide for Retail Traders/Investors to motivate them to become profitable Traders/Investors and then remain profitable. Equally important to experienced Retail Traders/Investors, as it reinforces winning trading strategies.
I seek understanding in everything but economics, markets and investing are where my mind is most at ease. In this I am forever doing research in my quest for answers. I do view the world from many different angles. Understanding economic behavioral patterns are important to me. Strategic investing over the medium to longer term is predominantly my focus when I contemplate my research or philosophies. I have a compulsion to express my thoughts in ordered form and my essays are the result of such expressions. I'm an economist by training, a financial engineer by talent, a banker by profession, a trader by interest and a father by chance.
Summary
- Model update from 14 December 2021 to 21 December 2021.
- Down leg still in place for all three even though some short term positive momentum materialized.
- Longer term oscillators are negative and negative momentum is increasing.
The description of the method and use of the model is published on Seeking Alpha here:
Algorithmic Models: Introducing Oscillator Trading
https://seekingalpha.com/article/4474322-algorithmic-models-introducing-oscillator-trading
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.